We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
Catalyst Biosciences Inc is a clinical-stage biopharmaceutical company. It mainly focuses on developing novel medicines to address serious medical conditions for individuals in need of treatment options. The company emphasizes product development efforts in the field of hemostasis and to develop val... Catalyst Biosciences Inc is a clinical-stage biopharmaceutical company. It mainly focuses on developing novel medicines to address serious medical conditions for individuals in need of treatment options. The company emphasizes product development efforts in the field of hemostasis and to develop valuable therapies for individuals with hemophilia. It is engaged in the clinical development of improved, next-generation subcutaneous prophylaxis using enhanced potency Factor VIIa and Factor IX variants. Show more
Data readout from Phase 3 clinical trial in the People's Republic of China (“PRC”) evaluating F351 for the treatment of CHB-associated liver fibrosis expected by early 2025 U.S. Phase 2a clinical...
SAN DIEGO, March 21, 2024 (GLOBE NEWSWIRE) -- Gyre Therapeutics (“Gyre”) (Nasdaq: GYRE), a clinical-stage biotechnology company developing anti-fibrotic therapeutics for a variety of chronic...
Totus Medicines Announces Appointment of Nassim Usman, Ph.D., as President & CEO and the Closing of a $66M Series B Funding PR Newswire EMERYVILLE, Calif., Dec. 15, 2023 EMERYVILLE, Calif...
SAN DIEGO, Nov. 13, 2023 (GLOBE NEWSWIRE) -- Gyre Therapeutics (“Gyre”) (NASDAQ: GYRE), a clinical-stage biotechnology company developing anti-fibrotic therapeutics for a variety of chronic...
| Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -1.19 | -7.28720146969 | 16.33 | 17.25 | 13.5 | 95255 | 15.52358605 | CS |
| 4 | -1.86 | -10.9411764706 | 17 | 17.25 | 13.3241 | 78313 | 15.73216539 | CS |
| 12 | 2.93 | 23.9967239967 | 12.21 | 26.37 | 10.41 | 77014 | 17.27952191 | CS |
| 26 | 8.74 | 136.5625 | 6.4 | 30.4 | 6.32 | 97359 | 18.73323191 | CS |
| 52 | 8.14 | 116.285714286 | 7 | 30.4 | 5.88 | 95991 | 18.61391393 | CS |
| 156 | 8.14 | 116.285714286 | 7 | 30.4 | 5.88 | 95991 | 18.61391393 | CS |
| 260 | 8.14 | 116.285714286 | 7 | 30.4 | 5.88 | 95991 | 18.61391393 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
